Search Results - "Um, S L"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1
  2. 2

    Evaluation of anti‐activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alfa (activated) by YAN, S. B., BRANDT, J. T., CORRELL, N. L., UM, S. L., BOURDAGE, J. S.

    Published in Journal of thrombosis and haemostasis (01-11-2009)
    “…Background: Drotrecogin alfa (activated) (DAA) is a recombinant human activated protein C (APC), which is an antithrombotic protein. Objectives: To evaluate…”
    Get full text
    Journal Article
  3. 3

    Human group II 14 kDa phospholipase A2 activates human platelets by Polgár, J, Kramer, R M, Um, S L, Jakubowski, J A, Clemetson, K J

    Published in Biochemical journal (01-10-1997)
    “…Recombinant human group II phospholipase A2 (sPLA2) added to human platelets in the low microg/ml range induced platelet activation, as demonstrated by…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Quantitative detection of platelet GPIIb-IIIa receptor antagonist activity using a flow cytometric method by Green, Lisa J., Marder, Philip, Um, Suzane L., Jakubowski, Joseph A., Lawrence, Jeffry B.

    “…Platelet‐membrane surface receptors are important targets for pharmacologic intervention in cardiovascular disease. Among these, glycoprotein (GP) IIb‐IIIa is…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Evaluation of anti-activated protein C antibody development in patients with severe sepsis from four clinical studies with drotrecogin alpha (activated) by Yan, S B, Brandt, J T, Correll, N L, Um, S L, Bourdage, J S

    Published in Journal of thrombosis and haemostasis (01-11-2009)
    “…Drotrecogin alpha (activated) (DAA) is a recombinant human activated protein C (APC), which is an antithrombotic protein. To evaluate the development of…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Phenothiazines as lipid peroxidation inhibitors and cytoprotective agents by Yu, Melvin J, McCowan, Jefferson R, Thrasher, K. Jeff, Keith, Priscilla T, Luttman, Charlotte A, Ho, Peter P. K, Towner, Richard D, Bertsch, Barbara, Horng, J. S

    Published in Journal of medicinal chemistry (01-02-1992)
    “…A series of phenothiazines was synthesized and evaluated as in vitro inhibitors of iron-dependent lipid peroxidation. The MIC (minimum tested concentration…”
    Get full text
    Journal Article
  11. 11

    Dihydroisoquinolone RGD mimics. Exploration of the aspartate isostere by Fisher, Matthew J., Gunn, Bruce P., Harms, Cathy S., Kline, Allen D., Mullaney, Jeffrey T., Scarborough, Robert M., Skelton, Marshall A., Um, Suzane L., Utterback, Barbara G., Jakubowski, Joseph A.

    Published in Bioorganic & medicinal chemistry letters (07-10-1997)
    “…Disubstituted 3,4-dihydroisoquinolones that contain an ether-linked benzamidine at C 6 and a β-substituted aspartate mimic at C 2 offer enhanced affinity for…”
    Get full text
    Journal Article
  12. 12

    New insights into the protein C pathway: potential implications for the biological activities of drotrecogin alfa (activated) by Macias, William L, Yan, S Betty, Williams, Mark D, Um, Suzane L, Sandusky, George E, Ballard, Darryl W, Planquois, Jean-Michel S

    Published in Critical care (London, England) (01-01-2005)
    “…It has been hypothesized that the protein C pathway is a pivotal link between the inflammation and coagulation cascades. The demonstration that a survival…”
    Get full text
    Journal Article
  13. 13

    Effect of drotrecogin alfa (activated) on human endothelial cell permeability and Rho kinase signaling by Zeng, Wei, Matter, William F, Yan, S Betty, Um, Suzane L, Vlahos, Chris J, Liu, Ling

    Published in Critical care medicine (01-05-2004)
    “…OBJECTIVE:To explore whether the improvement in organ function and the vasoactive effect observed in the clinical studies of drotrecogin alfa (activated)…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Systemic host inflammatory and coagulation response in the Dengue virus primo-infection by Avila-Aguero, Marı́a L, Avila-Aguero, Claudio R, Um, Suzane L, Soriano-Fallas, Alejandra, Cañas-Coto, Alejandro, Yan, S.Betty

    Published in Cytokine (Philadelphia, Pa.) (21-09-2004)
    “…Dengue virus infection has been rising in tropical countries. Clinical manifestations range from fever and general malaise to hemorrhagic manifestations and…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Platelet glycoprotein IIb–IIIa receptor (GPIIb–IIIa) antagonists derived from amidinoindoles by Sall, Daniel J., Arfsten, Ann E., Berry, Dennis R., Denney, Michael L., Harms, Cathy S., McCowan, Jefferson R., Ray, Judith K., Scarborough, Robert M., Um, Suzane L., Utterback, Barbara G., Jakubowski, Joseph A.

    Published in Bioorganic & medicinal chemistry letters (09-01-1996)
    “…A series of substituted amidinoindoles have been prepared as mimics of the RGD sequence and were studied as antagonists of the platelet glycoprotein IIb–IIIa…”
    Get full text
    Journal Article